Loading clinical trials...
Loading clinical trials...
A Phase 2, Double-blind, Randomized Study of BGB-290 Versus Placebo as Maintenance Therapy in Patients With Inoperable Locally Advanced or Metastatic Gastric Cancer That Responded to Platinum-based First-line Chemotherapy
Conditions
Interventions
Pamiparib
Placebo
Locations
65
United States
Miami Cancer Institute
Miami, Florida, United States
Scri Florida Cancer Specialist East
West Palm Beach, Florida, United States
Goshen Center For Cancer Care
Goshen, Indiana, United States
Cancer Center of Kansas
Wichita, Kansas, United States
Norton Cancer Institute
Louisville, Kentucky, United States
Novant Health Hematology Charlotte
Charlotte, North Carolina, United States
Start Date
July 3, 2018
Primary Completion Date
June 18, 2020
Completion Date
January 3, 2023
Last Updated
October 26, 2024
Lead Sponsor
BeiGene
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions